Lorundrostat

N/A

Report date: 2026/03/11 17:08:09
NME

Base Information

Drug NameLorundrostat
Drug Alias NameLorundrosatMT-4129MLS-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 11B2 inhibitors
TargetsCytochrome P450 11B2
Therapy Area/IndicationsHypertensionRenal Insufficiency, ChronicSleep Apnea, Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaCanadaUnited States +[13] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesMineralys Therapeutics Inc
Inactive CompaniesMitsubishi Tanabe Pharma Corp
Active IndicationsHypertensionRenal Insufficiency, ChronicSleep Apnea, Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG